Silo Pharma Inc SILO

Healthcare Psychedelics

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company’s two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company’s research and development programs are conducted through collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Balt...

NDAQ:SILO - Post by User

Silo Pharma Inc

<< Previous

Bullboard Posts

Next >>

(153)
•••

Post by coolfooldumbguyon Jul 16, 2024 11:53am

56 Views

Post# 36134826

This stock is still cheap.

Got some this morning at $1.98 per share at 10:35 A.M. It is a hold for me until year end.This stock is not a day trade. You should die your own due diligence,so glta.

<< Previous

Bullboard Posts

Next >>

Mink Ventures defines eight new high-priority drill targets